Home Newsfeeds Cocrystal Pharma Q2 EPS $(0.25) Down From $(0.04) YoY

Cocrystal Pharma Q2 EPS $(0.25) Down From $(0.04) YoY

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.25) per share. This is a 525 percent decrease over losses of $(0.04) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.25) per share. This is a 525 percent decrease over losses of $(0.04) per share from the same period last year.

B of A Securities Maintains Buy on Domino’s Pizza, Lowers Price Target to $490

By Benzinga Newsdesk

July 22, 7:42 AM

B of A Securities analyst Sara Senatore maintains Domino's Pizza (NYSE:DPZ) with a Buy and lowers the price target from $512 to $490.

DPZ

Wells Fargo Downgrades Momentive Glb to Equal-Weight, Lowers Price Target to $9.46

By Benzinga Newsdesk

March 14, 11:27 AM

Wells Fargo analyst Brian Fitzgerald downgrades Momentive Glb (NASDAQ:MNTV) from Overweight to Equal-Weight and lowers the price target from $10 to $9.46.

MNTV

New Apple iPhone 14 Is Out, With New Emergency SOS Via Satellite. And No More Sim Trays

By Mohit Manghnani

September 7, 2:13 PM

Apple Inc (NASDAQ: AAPL) introduced the much-awaited iPhone 14 and the iPhone Plus. The 14 will have a 6.1-inch display, and the plus model will have a 6.7-inch display. It sports the new A15 Bionic chip and all-day battery life.

AAPL